Canal Biosciences, Inc.

Biotech Lowell, MA

About

Issuer

Entity type
Corporation
Jurisdiction
Delaware
Sector
Biotech
Headquarters
Lowell, MA
Street
110 Canal Street
Zip
01852

Offering

Total offering
$3.2M
Amount sold
$2.3M
First sale
Mar 18, 2026
Min investment
$0
Securities
Equity
Federal exemption
Rule 506(b)
Investors so far
18

How this filing compares

Ranked #21 of 47 Biotech filings in April 2026 by offering amount.

Median Biotech filing in April 2026: $3M. This offering is 1.1× the median.

Other Massachusetts filings this week: ALPINE TORTILLA HOLDCO, INC., Base Camp Fund, Base Camp Fund II, BROOKDALE INTERNATIONAL PARTNERS, L.P., Cahaba Partners Core Fixed Income Fund

Leadership

Yu Zheng — Executive Officer (also: Director)

Christopher Benoit — Executive Officer (also: Director)

Jack Percoskie — Executive Officer

Filing details

Canal Biosciences, Inc. filed a Form D with the SEC on April 13, 2026.

Other newest Biotech companies

Other newest companies in Massachusetts